Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer

Journal of Virology

Volumn 82, Issue 2, 2008, Pages 630-637

  Belousova, Natalya ^a   Mikheeva, Galina ^a   Gelovani, Juri ^a   Krasnykh, Victor ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LIGAND; MOLECULAR MARKER; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE VECTOR; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS; PROTEIN TARGETING; TRANSGENE; VIRUS CAPSID;

ADENOVIRUSES, HUMAN; CAPSID PROTEINS; CELL LINE; GENE THERAPY; GENETIC VECTORS; HUMANS; LIGANDS; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; MIRIDAE;

EID: 37849014587     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01896-07     Document Type: Article

References (34)

1. Belousova, N., N. Korokhov, V. Krendelshehikova, V. Simonenko, G. Mikheeva, P. L. Triozzi, W. A. Aldrich, P. T. Banerjee, S. D. Gillies, D. T. Curiel, and V. Krasnykh. 2003. Genetically targeted adenovirus vector directed to CD40-expressing cells. J. Virol. 77:11367-11377.
2. Belousova, N., V. Krendelchtchikova, D. T. Curiel, and V. Krasnykh. 2002. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J. Virol. 76:8621-8631.
3. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
4. Binz, H. K., P. Amstutz, and A. Pluckthun. 2005. Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 23:1257-1268.
5. Campos, S. K., and M. A. Barry. 2007. Current advances and future challenges in adenoviral vector biology and targeting. Curr. Gene Ther. 7:189-204.
6. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
7. Chroboczek, J., R. W. Ruigrok, and S. Cusack. 1995. Adenovirus fiber. Curr. Top. Microbiol. Immunol. 199:163-200.
8. Dmitriev, I., V. Krasnykh, C. R. Miller, M. Wang, E. Kashentseva, G. Mikheeva, N. Belousova, and D. T. Curiel. 1998. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72:9706-9713.
9. Friedman, M., E. Nordberg, I. Hoiden-Guthenberg, H. Brismar, G. P. Adams, F. Y. Nilsson, J. Carlsson, and S. Stahl. 2007. Phage display selection of affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. Protein Eng. Des. Sel. 20:189-199.
10. Havenga, M., R. Vogels, D. Zuijdgeest, K. Radosevic, S. Mueller, M. Sieuwerts, F. Weichold, I. Damen, J. Kaspers, A. Lemckert, M. van Meerendonk, R. van der Vlugt, L. Holterman, D. Hone, Y. Skeiky, R. Mintardjo, G. Guussen, D. Barouch, J. Sadoff, and J. Goudsmit. 2006. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. J. Gen. Virol. 87:2135-2143.
11. Henry, L. J., D. Xia, M. E. Wilke, J. Deisenhofer, and R. D. Gerard. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68:5239-5246.
12. Hong, J. S., and J. A. Engler. 1996. Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 70:7071-7078.
13. Imperiale, M. J., and S. Kochanek. 2004. Adenovirus vectors: biology, design, and production. Curr. Top. Microbiol. Immunol. 273:335-357.
14. Jakubczak, J. L., M. L. Rollerice. D. A. Stewart, J. D. Jafari, D. J. Von Seggern, G. R. Nemerow, S. C. Stevenson, and P. L. Hallenbeck. 2001. Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J. Virol. 75:2972-2981.
15. Kobinger, G. P., H. Feldmann, Y. Zhi, G. Schumer, G. Gao, F. Feldmann, S. Jones, and J. M. Wilson. 2006. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346:394-401.
16. Krasnykh, V., N. Belousova, N. Korokhov, G. Mikheeva, and D. T. Curiel. 2001. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75:4176-4183.
17. Krasnykh, V., I. Dmitriev, G. Mikheeva, C. R. Miller, N. Belousova, and D. T. Curiel. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72:1844-1852.
18. Krasnykh, V. N., J. T. Douglas, and V. W. van Beusechem. 2000. Genetic targeting of adenoviral vectors. Mol. Ther. 1:391-405.
19. Magnussen, M. K., P. Henning, S. Myhre, M. Wikman, T. G. Uil, M. Friedman, K. M. Andersson, S. S. Hong, R. C. Hoeben, N. A. Habib, S. Stahl, P. Boulanger, and L. Lindholm. 2007. Adenovirus 5 vector genetically retargeted by an affibody molecule with specificity for tumor antigen HER2/ neu. Cancer Gene Ther. 14:468-479.
20. Magnussen, M. K., S. See Hong, P. Henning, P. Boulanger, and L. Lindholm. 2002. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J. Gene Med. 4:356-370.
21. Menard, S., S. M. Pupa, M. Campiglio, and E. Tagliabue. 2003. Biologic and therapeutic role of HER2 in cancer. Oncogene 22:6570-6578.
22. Mercier, G. T., J. A. Campbell, J. D. Chappell, T. Stehle, T. S. Dermody, and M. A. Barry. 2004. A chimeric adenovirus vector encoding reovirus attachment protein sigmal targets cells expressing junctional adhesion molecule 1. Proc. Natl. Acad. Sci. USA 101:6188-6193.
23. Nord, K., E. Gunneriusson, J. Ringdahl, S. Stahl, M. Uhlen, and P. A. Nygren. 1997. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat. Biotechnol. 15:772-777.
24. Orlova, A., M. Magnussen, T. L. Eriksson, M. Nilsson, B. Larsson, I. Hoiden-Guthenberg, C. Widstrom, J. Carlsson, V. Tolmachev, S. Stahl, and F. Y. Nilsson. 2006. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 66:4339-4348.
25. Schagen, F. H., F. M. Wensveen, J. E. Carette, T. S. Dermody, W. R. Gerritsen, and V. W. van Beusechem. 2006. Genetic targeting of adenovirus vectors using a reovirus sigmal-based attachment protein. Mol. Ther. 13:997-1005.
26. Steffen, A. C., A. Orlova, M. Wikman, F. Y. Nilsson, S. Stahl, G. P. Adams, V. Tolmachev, and J. Carlsson. 2006. Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. Eur. J. Nucl. Med. Mol. Imaging 33:631-638.
27. Steffen, A. C., M. Wikman, V. Tolmachev, G. P. Adams, F. Y. Nilsson, S. Stahl, and J. Carlsson. 2005. In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biother. Radiopharm. 20:239-248.
28. Tang, Y., D. Scollard, P. Chen, J. Wang, C. Holloway, and R. M. Reilly. 2005. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments. Nucl. Med. Commun. 26:427-432.
29. Tomko, R. P., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94:3352-3356.
30. Von Seggern, D. J., S. Huang, S. K. Fleck, S. C. Stevenson, and G. R. Nemerow. 2000. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J. Virol. 74:354-362.
31. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:257-264.
32. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
33. Wikman, M., A. C. Steffen, E. Gunneriusson, V. Tolmachev, G. P. Adams, J. Carlsson, and S. Stahl. 2004. Selection and characterization of HER2/ neu-binding affibody ligands. Protein Eng. Des. Sel. 17:455-462.
34. Xia, H., B. Anderson, Q. Mao, and B. L. Davidson. 2000. Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J. Virol. 74:11359-11366.